TY  - JOUR
AU  - Martín, Ernesto
AU  - López-Aguilera, José
AU  - González-Manzanares, Rafael
AU  - Anguita, Manuel
AU  - Gutiérrez, Guillermo
AU  - Luque, Aurora
AU  - Paredes, Nick
AU  - Oneto, Jesús
AU  - Perea, Jorge
AU  - Castillo, Juan Carlos
PY  - 2021
DO  - 10.3390/jcm10030505
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/28309
T2  - Journal of clinical medicine
AB  - Heart failure (HF) is one of the mayor contributors to cardiovascular morbidity and mortality in patients with diabetes. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated to reduce the risk of hospitalization for HF in patients with...
LA  - en
KW  - N-terminal pro-B-type natriuretic peptide
KW  - canagliflozin
KW  - heart failure
KW  - readmissions
KW  - sodium glucose co-transporter 2 inhibitor
TI  - Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.
TY  - research article
VL  - 10
ER  -